Navigation Links
Use of Clinical Endpoint Adjudication Committees Finding Increasing Favor with Regulators

BALA CYNWYD, Pa., March 28, 2011 /PRNewswire/ -- Applied Clinical Intelligence, LLC (ACI), an industry leader in clinical endpoint adjudication committees and independent data monitoring committees (, announces the opening of registration for a complimentary breakfast seminar in Cambridge, MA. The 90-minute seminar will focus on aligning independent expert committees with development goals.  This is a unique opportunity to learn practical advice about effective design and management of Clinical Endpoint Committees (CECs) and Endpoint Adjudication Committees (EACs).

"The regulatory pressure for independent adjudication of composite endpoints is escalating, and we want to make sure that those involved in drug, biotech, and device development understand the potential regulatory issues," said Dr. Jonathan Seltzer, MD, MBA, FACC, President and CEO of ACI.  Please join us for this unique learning opportunity.  For your convenience, the seminar is being offered on both April 5th and April 6th in Cambridge, MA from 8:30 a.m. to 10 a.m. ACI will also host seminars in different regions over the next few months.  Registration details for this complimentary seminar are available at

Topics will include:

  • Practical issues with adjudication of Composite Endpoints and MACE
  • Regulatory strategy for Clinical Endpoint Adjudication
  • Independent Expert Compensation and Sunshine Laws
  • Issues with Image Adjudication presented by Intrinsic Imaging (

Please also visit our iCommittees™ website for more information:

About Applied Clinical Intelligence

ACI provides integrated and highly efficient risk reduction solutions for clinical research.  iCommittees™ is a comprehensive, independent expert committee solution offering management, regulatory-grade biostatistical support, automated processes and documentation expertise for Data Monitoring Committees (DSMBs) and EACs.  Founded in 2001, ACI is headquartered in the Philadelphia area and has deployed its automated solutions to hundreds of trials in over 50 countries.  For more information, please visit

Kelly Ryan

SOURCE Applied Clinical Intelligence, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
Breaking Medicine News(10 mins):